Development of Biomarkers for Radiation Biodosimetry and Medical Countermeasures Research: Current Status, Utility, and Regulatory Pathways
Radiat Res
.
2022 May 1;197(5):554-558.
doi: 10.1667/RADE-21-00213.1.
Authors
Thomas A Winters
1
,
Lanyn P Taliaferro
1
,
Merriline M Satyamitra
1
Affiliation
1
Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland.
PMID:
35130340
PMCID:
PMC10283012
DOI:
10.1667/RADE-21-00213.1
No abstract available
MeSH terms
Biomarkers
Medical Countermeasures*
Radioactive Hazard Release*
Radiometry
Substances
Biomarkers
Grants and funding
Z99 AI999999/ImNIH/Intramural NIH HHS/United States